ELife

TLI Investigator Dr. Wei Yan Named Editor-in-Chief of the Andrology Journal

Retrieved on: 
Monday, March 18, 2024
Reproduction, Lundquist, Managing editor, Infertility, SSR, Male, Social media, Research, Fertility, Doctor of Philosophy, MD, Biology of Reproduction, Society, ELife, Biology, Reproductive medicine, UCLA, Management

Dr. Yan's appointment to Andrology is a testament to his dedication to reproductive medicine.

Key Points: 
  • Dr. Yan's appointment to Andrology is a testament to his dedication to reproductive medicine.
  • With over 160 peer-reviewed publications and numerous awards, Dr. Yan is a committed researcher and educator.
  • Dr. Yan's vision for Andrology is to enhance its global influence and implement innovative strategies.
  • His plans include prioritizing cutting-edge reviews, rewarding high-quality contributions, and fostering the next generation of researchers through the Trainee Reviewer Program.

Beckman Foundation Announces Publication of Results from Multi-year Study on Impact of Blinded Application Reviews on Institutional Prestige Bias in eLife

Retrieved on: 
Tuesday, March 26, 2024
Crossref, DOI, Letter, Organization, University, BYI, Bangladesh Technical Education Board, Bias, Research, Policy, Average, LOI, ELife, Workload, Beckman Institute, Pharmaceutical industry

IRVINE, Calif., March 26, 2024 /PRNewswire-PRWeb/ -- 

Key Points: 
  • The Arnold and Mabel Beckman Foundation announced today that eLife published results from a multi-year study of the Beckman Young Investigator program which demonstrates the positive impact of blinded application reviews on mitigating institutional prestige bias.
  • - Dr. Anne Hultgren, Beckman Foundation Executive Director
    "I feel strongly that Dr. and Mrs. Beckman would be extremely proud of this work by the Foundation.
  • One of the early steps was to define "institutional prestige" for the purposes of evaluating systemic bias within the review process.
  • "Meta-Research: Blinding Reduces Institutional Prestige Bias During Initial Review of Applications for a Young Investigator Award" was authored by Anne E. Hultgren and Nicole M.F.

Genetic testing Gene Solutions spearheads in promoting preventive care at ESMO Asia 2023

Retrieved on: 
Tuesday, December 5, 2023
Liver, NGS, ELife, Biotechnology, ASCO, Research, Breast, Health, The, Genetics, Cancer, Liquid biopsy, Medicine, Poster, Congress, Genetic testing, Patient, Diagnosis, Marker beacon, Methylation, Agriculture

As the only representative of South East Asia at the 2023 congress, Gene Solutions introduced its achievements in Next-generation sequencing (NGS), presenting significant steps forward in personalized medicine in cancer treatment.

Key Points: 
  • As the only representative of South East Asia at the 2023 congress, Gene Solutions introduced its achievements in Next-generation sequencing (NGS), presenting significant steps forward in personalized medicine in cancer treatment.
  • Gene Solutions has made impressive strides in the region, present in Vietnam, Thailand, Philippines, Malaysia, Indonesia, and now Singapore.
  • Earlier in 2023, Gene Solutions’ clinical research success was recognized at The ASCO Breakthrough in Japan, with two ASCO Breakthrough Abstract Awards.
  • Gene Solutions is leading a much-needed paradigm shift in healthcare by embracing the most recent developments in genetic research, encouraging preventive care, and motivating people to take control of their health,” said Dr. Nguyen Huu Nguyen.

Unlock a treasure trove of savings on popular smart home products: EZVIZ's long-awaited and unusual Black Friday discounts are now live

Retrieved on: 
Friday, November 17, 2023
Sale, Amazon (company), Safety, Love, Privacy, ELife, Doorbell, DB2, CB8, Family, Motion, Black Friday, Nightclub, Satellite navigation device

HOOFDDORP, The Netherlands, Nov. 17, 2023 (GLOBE NEWSWIRE) -- EZVIZ, a global leading smart home technology company, is excited to announce its highly anticipated Black Friday sale. By slashing prices on some of its most advanced products, EZVIZ is serious about enhancing safety and smartness in every home, with exclusive offers that are hard to resist. From highly rated stylish battery cameras to award-winning video doorbells. EZVIZ reaffirms its mission to make protection more reliable and accessible than ever before, celebrating love, care and peace-of-mind of family during this shopping festival.

Key Points: 
  • EZVIZ reaffirms its mission to make protection more reliable and accessible than ever before, celebrating love, care and peace-of-mind of family during this shopping festival.
  • The enchantment of the sale will last 11 days, from November 17 to November 27.
  • Smart home lovers can hunt for EZVIZ’s hot deals on the company’s official online stores, Amazon UK , or through its local retail partners.
  • Users can enjoy privacy protection through the voice changer feature and create non-filming zones to monitor only the necessary areas.

Stowers scientists find evidence of unintended impacts from anti-cancer drugs

Retrieved on: 
Wednesday, August 23, 2023
DNA, Drug development, Failure, Protein kinase, Stowers Institute for Medical Research, Enzyme, Toxicity, Research, Cell, RNA, Protein, Potapov, Cancer, Logic, Cell nucleus, Health, Medical research, Ribosome, Pharmaceutical industry, Microscope, Dietary supplement, ELife

KANSAS CITY, Mo., Aug. 23, 2023 /PRNewswire/ -- With around 90% of drugs failing to make it to market, the potential for improving efficiency within the drug development industry is clear. Drugs designed to combat cancers suffer similar rates of failure for many reasons. Now, researchers have revealed one reason why certain anti-cancer compounds can cause unexpected side effects. This research could help guide an understanding of why some drugs show more promise than others, providing a new tool that can be used to identify those drugs and drug candidates.

Key Points: 
  • This research could help guide an understanding of why some drugs show more promise than others, providing a new tool that can be used to identify those drugs and drug candidates.
  • Thus, the team found a way to capitalize on this variation and asked how chemotherapy drugs impact the nucleolus, causing nucleolar stress.
  • "In this study, we not only evaluated how anti-cancer drugs alter the appearance of nucleoli, but also identified categories of drugs that cause distinct nucleolar shapes," said Gerton.
  • Drugs often fail in clinical trials due to excessive and unintended toxicity that can be caused by their off-target effects.

EZVIZ unveils exciting Prime Day 2023 deals on smart home devices, offering large discounts on its best items

Retrieved on: 
Monday, July 10, 2023
Solar panel, ELife, Privacy, Amazon (company), Amazon, DB2, Motion, Base station, GB, Online shopping, Television, Video game

HOOFDDORP, Netherlands, July 10, 2023 /PRNewswire/ -- EZVIZ, a leading smart home brand, is ready to enter people's Prime Day shopping hauls with many highly attempted deals on its best-sellers, from advanced security cameras to internet-connected video doorbells. As one of the most anticipated sales events of the year, this Prime Day will witness how EZVIZ provides customers with cost-saving chances to level up their smart home experience with reliable and easy-to-use devices.

Key Points: 
  • HOOFDDORP, Netherlands, July 10, 2023 /PRNewswire/ -- EZVIZ, a leading smart home brand, is ready to enter people's Prime Day shopping hauls with many highly attempted deals on its best-sellers, from advanced security cameras to internet-connected video doorbells.
  • As one of the most anticipated sales events of the year, this Prime Day will witness how EZVIZ provides customers with cost-saving chances to level up their smart home experience with reliable and easy-to-use devices.
  • The flexible EZVIZ products can also seamlessly integrate into most people's existing smart home systems.
  • For more information about EZVIZ Prime Day 2023, please visit Amazon UK.

Bees are astonishingly good at making decisions – and our computer model explains how that's possible

Retrieved on: 
Tuesday, June 27, 2023
Psychology, Learning, Uncertainty, Honey, Human, Bee, Code, ELife, Reward, Flower, Research, Brain, History, Animal, Time, Machine learning, Primate, Mining, Engineering, Biology, Surveying

In new research published today in eLife our team reports how bees make these complex decisions.

Key Points: 
  • In new research published today in eLife our team reports how bees make these complex decisions.
  • We put tiny, harmless paint marks on the back of each bee, and filmed every visit a bee made to the flower array.
  • We then used computer vision and machine learning to automatically extract the position and flight path of the bee.
  • Our computer model of how bees were making fast, accurate decisions mapped well to both their behaviour and the known pathways of the bee brain.

SoftAtHome successfully delivers etisalat by e& UAE's smart living home control service with Amazon Alexa

Retrieved on: 
Tuesday, May 30, 2023
E (musical note), Music, E, SoftAtHome, Internet of things, Alexa, Smart, STB, Elif (TV series), ELife, Human, STB (TV channel), Amazon, VASP, Amazon Alexa, Raymond E. S. Williamson, Reading, Ecosystem, News, Ring (company), Etisalat by e&, Consumer electronics, Mobile phone, Online shopping

PARIS, May 30, 2023 /PRNewswire/ -- SoftAtHome, an independent software company for broadband, video, and analytics, today announced having been chosen by "etisalat by e&" as Alexa Voice control trusted solution provider to deliver the latest smart eLife Set-Top Box (STB) and backend software to enable Alexa voice control features in Arabic and English.

Key Points: 
  • United Arab Emirates (UAE) users can control connected smart home devices with voice commands thanks to Alexa's technology deployed by SoftAtHome.
  • SoftAtHome delivered the world's first STB support for ring cameras by enabling video streaming between Ring cameras and etisalat by e&'s entertainment platform eLife TV.
  • Khaled El Khouly, Chief Consumer Officer, etisalat by e& UAE, said: "It was great to integrate SoftAtHome with their expertise on Amazon Alexa being an added advantage in our new 'Smart Living Home Control' service, delivering the promise of smart living and differentiating from other regional service providers.
  • etisalat by e&'s Smart-living customers can now control connected smart home devices with Alexa voice commands, accessible and controllable through their eLife TV.

SoftAtHome successfully delivers etisalat by e& UAE's smart living home control service with Amazon Alexa

Retrieved on: 
Tuesday, May 30, 2023
E (musical note), Music, E, SoftAtHome, Internet of things, Alexa, Smart, STB, Elif (TV series), ELife, Human, STB (TV channel), Amazon, VASP, Amazon Alexa, Raymond E. S. Williamson, Reading, Ecosystem, News, Ring (company), Etisalat by e&, Consumer electronics, Mobile phone, Online shopping

PARIS, May 30, 2023 /PRNewswire/ -- SoftAtHome, an independent software company for broadband, video, and analytics, today announced having been chosen by "etisalat by e&" as Alexa Voice control trusted solution provider to deliver the latest smart eLife Set-Top Box (STB) and backend software to enable Alexa voice control features in Arabic and English.

Key Points: 
  • United Arab Emirates (UAE) users can control connected smart home devices with voice commands thanks to Alexa's technology deployed by SoftAtHome.
  • SoftAtHome delivered the world's first STB support for ring cameras by enabling video streaming between Ring cameras and etisalat by e&'s entertainment platform eLife TV.
  • Khaled El Khouly, Chief Consumer Officer, etisalat by e& UAE, said: "It was great to integrate SoftAtHome with their expertise on Amazon Alexa being an added advantage in our new 'Smart Living Home Control' service, delivering the promise of smart living and differentiating from other regional service providers.
  • etisalat by e&'s Smart-living customers can now control connected smart home devices with Alexa voice commands, accessible and controllable through their eLife TV.

eLife ends accept/reject decisions following peer review

Retrieved on: 
Wednesday, October 26, 2022
Preprint, Editorial, Reviewed, Medicine, Thought, Review, Publishing, Science, Peer review, Biology, Research, Board, Board of directors, Manuscript, Language, Medical device, Dietary supplement, Pharmaceutical industry, Book, Management, ELife

CAMBRIDGE, England, Oct. 26, 2022 /PRNewswire/ -- eLife is pleased to announce a major change in editorial practice. Building on its 2021 shift to exclusively reviewing preprints, the organisation is ending the practice of making accept/reject decisions following peer review.

Key Points: 
  • eLife will emphasise the public peer review of preprints, restoring author autonomy and promoting the assessment of scientists based on what, not where, they publish.
  • Building on its 2021 shift to exclusively reviewing preprints, the organisation is ending the practice of making accept/reject decisions following peer review.
  • In the new process, eLife editors will invite expert reviewers to carry out high-quality peer review.
  • Fiona Hutton, eLife Head of Publishing, says: "Although the core process of peer review is largely unchanged, the output is fundamentally different.